Chengdu huasun technology group Inc. , LTD. (SZSE: 000790)
Health Care · Pharmaceuticals · CN
CN¥4.08
-1.45% today · -3.1% 1Y
Chengdu huasun technology group Inc. , LTD. (SZSE: 000790) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $378.55M and employs 727 people.
Over the last twelve months the share price has lost 3.1%, trading between 3.40 and 4.79.
Tweenvest scores Chengdu huasun technology group Inc. , LTD. across four factors: quality 61/100, value 43/100, growth 0/100. Its strongest factor is quality.
000790 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $378.55M
- Revenue (TTM)
- $76.53M
- P/E
- —
- EPS
- -0.48
- Dividend yield
- —
- Beta (5Y)
- 0.18
- 52-week high
- CN¥4.79
- 52-week low
- CN¥3.40
- Avg volume (3M)
- —
- Shares outstanding
- 623.72M
- Employees
- 727
- Next earnings
- —
About Chengdu huasun technology group Inc. , LTD.
Chengdu Huasun Technology Group Inc., Ltd., established in 1998, is a diversified enterprise operating from Chengdu, China. The company's core activities span both the pharmaceutical sector and the steel structure industry. In its pharmaceutical division, the company specializes in the manufacturing and distribution of various medicines, including modern and traditional Chinese remedies, as well as chemical pharmaceuticals. Additionally, it dedicates resources to the research, development, production, and marketing of biological products and advanced biotechnology drugs, particularly those targeting cardiovascular and cerebrovascular conditions. Beyond healthcare, Chengdu Huasun is also a prominent provider of comprehensive services for steel structure buildings. This includes the design, fabrication, installation, and maintenance of such constructions. The company's name was officially changed in April 2020, transitioning from its previous identity as Chengdu Taihe Health Technology Group Inc., Ltd.
- ISIN
- CNE0000001H5
- Founded
- 1988
- Listed since
- Mar 27, 1998
- Exchange
- Shenzhen Stock Exchange
- Currency
- CNY
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Eli Lilly and CompanyNYSE: LLY | $1.12T | $1,257.35 | +0.16% |
| Johnson & JohnsonNYSE: JNJ | $651.25B | $271.37 | +0.42% |
| Merck & Co., Inc.NYSE: MRK | $376.37B | $152.55 | +2.39% |
| Roche Holding AGSWX: ROP | $373.91B | CHF370.90 | -1.25% |
| Novartis AGSWX: NOVN | $302.17B | CHF127.42 | +0.85% |
| AstraZeneca PLCLSE: AZN | $258.76B | £121.48 | -0.76% |
| Novo Nordisk A/SCPSE: NOVO B | $207.84B | Dkr300.85 | +1.59% |
| Pfizer Inc.NYSE: PFE | $159.99B | $28.15 | +0.29% |
Figures last refreshed Aug 18, 2026.